Abstract
Expression of manganese superoxide dismutase (MnSOD), a nuclear-encoded mitochondrial primary antioxidant enzyme, is protective against various paradigms of oxidative stress-induced brain injury. We have shown previously that the presence of an intronic nuclear factor site, κB (NF-κB), in the MnSOD gene is essential for the induction of MnSOD by tumor necrosis factor α (TNF-α). However, whether activation of NF-κB is protective against oxidative stress-induced neuronal injury is unclear. In the present study, we demonstrate that TNF-α activates NF-κB activity in neuronal, SH-SY5Y, cells and preferentially enhances the binding of p50 and p65 to the promoter/enhancer regions of the MnSOD gene. Binding of NF-κB members to the MnSOD gene leads to the induction of MnSOD mRNA and protein levels. Consequently, induction of MnSOD by TNF-α primes neuronal cells to develop resistance against subsequent exposure to β-amyloid and FeSO4. Taken together, these results suggest that NF-κB might exert its protective function by induction of MnSOD leading to subsequent protection against oxidative stress-induced neuronal injury.
Similar content being viewed by others
References
Albensi B. C. and Mattson M. P. (2000) Evidence for the involvement of TNF and NF-kappa B in hippocampal synaptic plasticity. Synapse 35, 151–159.
Barger S. W., Horster D., Furukawa K., Goodman Y., Krieglstein J., and Mattson M. P. (1995) Tumor necrosis factor alpha and tumor necrosis factor beta protect neurons against amyloid beta-peptide toxicity: Evidence for Involvement of a kappa-b-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc. Natl. Acad. Sci. U. S. A. 92, 9328–9332.
Bhakar A. L., Tannis L. L., Zeindler C., Russo M. P., Jobin C., Park D. S., et al. (2002) Constitutive nuclear factor-kappa B activity is required for central neuron survival. J. Neurosci. 22, 8466–8475.
Bruce-Keller A. J., Geddes J. W., Knapp P. E., McFall R. W., Keller J. N., Holtsberg F. W., et al. (1999) Anti-death properties of TNF against metabolic poisoning: mitochondrial stabilization by MnSOD. J. Neuroimmunol. 93, 53–71.
Bui N. T., Livolsi A., Peyron J. F., and Prehn J. H. M. (2001) Activation of nuclear factor kappa B and bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of I kappa B alpha. J. Cell Biol. 152, 753–763.
Chen Z. J., Hagler J., Palombella V. J. Melandri F., Scherer D., Ballard D., and Maniatis T. (1995) Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin proteasome pathway. Genes Dev. 9, 1586–1597.
Combs C. K., Karlo J. C., Kao S. C., and Landreth G. E. (2001) Beta-Amyloid stimulation of microglia and monocytes results in TNF alpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 21, 1179–1188.
Diem R., Meyer R., Weishaupt J. H., and Bahr M. (2001) Reduction of potassium currents and phosphatidylinositol 3-kinase-dependent Akt phosphorylation by tumor necrosis factor-alpha rescues axotomized retinal ganglion cells from retrograde cell deathin vivo. J. Neurosci. 21, 2058–2066.
Floden A. M., Li S. S., and Combs C. K. (2005) Beta-Amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors. J. Neurosci. 25, 2566–2575.
Foehr E. D., Lin X., O'Mahony A., Geleziunas R., Bradshaw R. A., and Greene W. C. (2000) NF-kappa B signaling promotes both cell survival and neurite process formation in nerve growth factor-stimulated PC12 cells. J. Neurosci. 20, 7556–7563.
Gibson G. E., Huang H. M., and Chen H. L. (2005) Select oxidants produce changes in endoplasmic reticulum Ca2+ stores reminiscent of those in patients with Alzheimer. J. Neurochem. 94, 25,25.
Glazner G. W. and Mattson M. P. (2000) Differential effects of BDNF, ADNF9, and TNF alpha on levels of NMDA receptor subunits, calcium homeostasis, and neuronal vulnerability to excitotoxicity. Exp. Neurol. 161, 442–452.
Gonzalez-Zulueta M., Ensz L. M., Mukhina G., Lebovitz R. M., Zwacka R. M., Engelhardt J. F., et al. (1998) Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. J. Neurosci. 18, 2040–2055.
Gutierrez H., Hale V. A., Dolcet X., and Davies A. (2005) NF-kappa B signalling regulates the growth of neural processes in the developing PNS and CNS. Development 132, 1713–1726.
Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R. L., Atwood C. S., et al. (2001) Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21, 3017–3023.
Houzen H., Kikuchi S., Kanno M., Shinpo K., and Tashiro K. (1997) Tumor necrosis factor enhancement of transient outward potassium currents in cultured rat cortical neurons. J. Neurosci. Res. 50, 990–999.
Kaltschmidt B., Uherek M., Wellmann H., Volk B., and Kaltschmidt C. (1999) Inhibition of NF-kappa B potentiates amyloid beta-mediated neuronal apoptosis. Proc. Natl. Acad. Sci. U. S. A. 96, 9409–9414.
karin M. and Lin A. (2002) NF-kappa B at the crossroads of life and death. Nat. Immunol. 3, 221–227.
Keller J. N., Kindy M. S., Holtsberg F. W., St. Clair D. K., Yen H. C., Germeyer A., et al. (1998) Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 18, 687–697.
Kenchappa P., Yadav A., Singh G., Nandana S., and Banerjee K. (2004) Rescue of TNF alpha-inhibited neuronal cells by IGF-1 involves Akt and c-Jun N-terminal kinases. J. Neurosci. Res. 76, 466–474.
Klivenyi P., St. Clair D., Wermer M., Yen H. C., Oberley T., Yang L. C., and Beal M. F. (1998) Manganese superoxide dismutase overexpression attenuates MPTP toxicity. Neurobiol. Dis. 5, 253–258.
Li F., Calingasan N. Y., Yu F. M., Mauck W. M., Toidze M., Almeida C. G., et al. (2004) Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J. Neurochem. 89, 1308–1312.
Li Y. B., Copin J. C., Reola L. F., Calagui B., Gobbel G. T., Chen S. F., et al. (1998) Reduced mitochondrial manganese-superoxide dismutase activity exacerbates glutamate toxicity in cultured mouse cortical neurons. Brain Res. 814, 164–170.
Lyras L., Cairns N. J., Jenner A., Jenner P., and Halliwell B. (1997) An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68, 2061–2069.
Marchetti L., Klein M., Schlett K., Pfizenmaier K., and Eisel U. L. M. (2004) Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-asparta te receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J. Biol. Chem. 279, 32, 869–32, 881.
Marcus D. L., Thomas C., Rodriguez C., Simberkoff K., Tsai J. S., Strafaci J. A., and Freedman M. L. (1998) Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp. Neurol. 150, 40–44.
Mattson M. P. and Camandola S. (2001) NF-kappa B in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107, 247–254.
Mattson M. P., Culmsee C., Yu Z. F., and Camandola S. (2000) Roles of nuclear factor kappa B in neuronal survival and plasticity. J. Neurochem. 74, 443–456.
Mattson M.P., Goodman Y., Luo H., Fu W.M., and Furukawa K. (1997) Activation of NF-kappa B protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49, 681–697.
Michiels C., Raes M., Toussaint O., and Remacle J. (1994) Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-Sod for cell survival against oxidative stress. Free Radic. Biol. Med. 17, 235–248.
Oneill L. A. J. and Kaltschmidt C. (1997) NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20, 252–258.
Schneider A., Martin-Villalba A., Weih F., Vogel J., Wirth T., and Schwaninger M. (1999) NF-kappa B is activated and promotes cell death in focal cerebra lischemia. Nat. Med. 5, 554–559.
Stepanichev M. Y., Zdobnova I. M., Yakovlev A. A., Onufriev M. V., Lazareva N. A., Zarubenko H. I., and Gulyaeva N. V. (2003) Effects of tumor necrosis factor-alpha central administration on hippocampal damage in rat induced by amyloid beta-peptide (25–35). J. Neurosci. Res. 71, 110–120.
Sullivan P. G. and Brown M. R. (2005) Mitochondrial aging and dysfunction in Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 29, 407–410.
Szelenyi J. (2001) Cytokines and the central nervous system. Brain Res. Bull. 54, 329–338.
Takuma K., Yan S. S. D., Stern D. M., and Yamada K. (2005) Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer's disease. J. Pharmacol. Sci. 97, 312–316.
Tamatani M., Che Y. H., Matsuzaki H., Ogawa S., Okado H., Miyake S., et al. (1999) Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NF kappa B activation in primary hippocampal neurons. J. Biol. chem. 274, 8531–8538.
Tarkowski E., Blennow K., Wallin A., and Tarkowski A. (1999) Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J. Clin. Immunol. 19 223–230.
Varfolomeev E. E. and Ashkenazi A. (2004) Tumor necrosis factor: an apoptosis JuNKie?. Cell 116, 491–497.
Viel J. J., McManus D. Q., Smith S. S., and Brewer G. J. (2001) Age- and concentration-dependent neuroprotection and toxicity by TNF in cortical neurons from beta-amyloid. J. Neurosci. Res. 64, 454–465.
Vitkovic L., Bockaert J., and Jacque C. (2000) “Inflammatory’ cytokines: neuromodulators in normal brain? J. Neurochem. 74, 457–471.
Wajant H., Pfizenmaier K., and Scheurich P. (2003) Tumor necrosis factor signaling. Cell Dealth Differ. 10, 45–65.
Wan X. S. Devalaraja M. N., St. Clair D. K. (1994) Molecular structure and organization of the human manganese superoxide dismutase gene. DNA Cell Biol. 13, 1127–1136.
Wang J., Xiong S., Xie C., markesbery W. R., and Lovell M. A. (2005) Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J. Neurochem. 93, 953–962.
Weisiger R. A. and Fridovich I. (1973) Mitochondrial superoxide dismutase. Site of synthesis and intramitochondrial localization. J. Biol. Chem. 248, 4793–4796.
Xu Y., Kiningham K. K., Devalarja M. N., Yeh C. C., Majima H., Kasarskis E. J., and St. Clair D. K. (1999) An intronic NF-kappa B element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1 beta. DNA Cell Biol. 18, 709–722.
Yeh C. C., Wan X. S., and St. Clair D K. (1998) Transcriptional regulation of the 5′ proximal promoter of the human manganese superoxide dismutase gene. DNA Cell Biol. 17, 921–930.
Zhu C. H., Huang Y. H., Weydert C. J., Oberley L. W., and Domann F. E. (2001) Constitutive activation of transcription factor AP-2 is associated with decreased MnSOD expression in transformed human lung fibroblasts. Antioxid. Redox Signal. 3, 387–395.
Zou J. Y. and Crews F. T. (2005) TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition. Brain Res. 1034, 11–24.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sompol, P., Xu, Y., Ittarat, W. et al. NF-κB-Associated MnSOD induction protects against β-amyloid-induced neuronal apoptosis. J Mol Neurosci 29, 279–288 (2006). https://doi.org/10.1385/JMN:29:3:279
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1385/JMN:29:3:279